Vraylar

Active Ingredient(s): Cariprazine
FDA Approved: * September 17, 2015
Pharm Company: * FOREST LABS LLC
Category: Antipsychotic

Cariprazine, sold under the brand names Vraylar in the United States and Reagila in the European Union, is an atypical antipsychotic which is used in the treatment of schizophrenia, bipolar mania,[4] and bipolar depression.[5] It acts primarily as a D3 receptor and D2 receptor partial agonist, with high selectivity for the D3 receptor.[6] Positive Phase III study results were published for schizophrenia and mania in early 2012, and for bipolar d... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Vraylar 1.5 mg Oral Capsule, Gelatin Coated
NDC: 61874-115
Labeler:
Actavis Pharma, Inc.
Vraylar 3 mg Oral Capsule, Gelatin Coated
NDC: 61874-130
Labeler:
Actavis Pharma, Inc.
Vraylar 4.5 mg Oral Capsule, Gelatin Coated
NDC: 61874-145
Labeler:
Actavis Pharma, Inc.
Vraylar 6 mg Oral Capsule, Gelatin Coated
NDC: 61874-160
Labeler:
Actavis Pharma, Inc.
Vraylar Oral Kit
NDC: 61874-170
Labeler:
Actavis Pharma, Inc.
Vraylar 6 mg Oral Capsule, Gelatin Coated
NDC: 70518-3157
Labeler:
Remedyrepack Inc.

Popular Topics

Vraylar side effects

Hi. I have started taking Vraylar 4.5 mgs daily as an antidepressant stimulator. I was wondering if anyone here has or i...

2 REPLIES
Vraylar and urinary incontinence

Hi I'm Armando. I started taking vraylar 4.5 mgs. about 2 and a half months ago. After a few days, I started getting...

1 REPLY
Does anyone have any knowledge about a medication VRAYLAR

VRAYLAR, My doctor has prescribed this medication to me yesterday the starting dose is 1.5mg. I know nothing about it. I...

3 REPLIES